CLINICAL TRIALS PROFILE FOR MAPRACORAT
✉ Email this page to a colleague
Clinical Trials for Mapracorat
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00905450 ↗ | Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery | Completed | Bausch & Lomb Incorporated | Phase 2 | This clinical study is being conducted to identify the most effective drug concentration and dose frequency of BOL-303242-X (Mapracorat) ophthalmic suspension, for the treatment of inflammation following cataract surgery. |
NCT01228513 ↗ | Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD) | Completed | Bayer | Phase 2 | The purpose of this study is to evaluate the efficacy and safety of three concentrations of a development drug compared to placebo in the treatment of atopic dermatitis. |
NCT01230125 ↗ | Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery | Completed | Bausch & Lomb Incorporated | Phase 3 | The objective of this clinical study is to compare the safety and efficacy of Mapracorat Ophthalmic Suspension, 3% to vehicle for the treatment of postoperative inflammation and pain following cataract surgery. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Mapracorat
Condition Name
Clinical Trial Locations for Mapracorat
Trials by Country
Clinical Trial Progress for Mapracorat
Clinical Trial Phase
Clinical Trial Sponsors for Mapracorat
Sponsor Name